All News

Strategy

Delivering on the Promise of Cell and Gene Therapy Distributed and Point-of-Care Manufacturing
31 July 2023
Delivering on the Promise of Cell and Gene Therapy Distributed and Point-of-Care Manufacturing
At Advanced Therapies Week 2023,
Workshop: A Design Team’s Views on Optimizing your Viral Vector for Clinical Success
20 July 2023
Workshop: A Design Team’s Views on Optimizing your Viral Vector for Clinical Success
A discussion on the design,
Cell Sorter for Next Cell Therapy Products: The Sangamo & Sony Biotechnology Journey
20 July 2023
Cell Sorter for Next Cell Therapy Products: The Sangamo & Sony Biotechnology Journey
This Briefing from Advanced Therapies
The Next Wave: Cell and Gene Therapy’s Commercial Shift
20 July 2023
The Next Wave: Cell and Gene Therapy’s Commercial Shift
This full session from Advanced
POPULAR NEWS ITEMS
Image
21 September 2023

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image
20 September 2023

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image
20 September 2023

The Cell & Gene Therapy Manufacturing Capacity Map

Vertex and Lonza Unite to Build Dedicated Facility for Type 1 Diabetes Cell Therapies
27 June 2023
Vertex and Lonza Unite to Build Dedicated Facility for Type 1 Diabetes Cell Therapies
Vertex and Lonza announce strategic
Anthony Nolan and MicrofluidX Partner to Revolutionize the Development of Cell and Gene Therapies
23 June 2023
Anthony Nolan and MicrofluidX Partner to Revolutionize the Development of Cell and Gene Therapies
MicrofluidX will be testing its
Yposkesi Expands with State-of-the-Art $60M Biomanufacturing Facility for Cell and Gene Therapies
22 June 2023
Yposkesi Expands with State-of-the-Art $60M Biomanufacturing Facility for Cell and Gene Therapies
Yposkesi doubles its viral vector
Development of a Robust Scalable Suspension Platform for AAV Manufacturing up to 2000L
20 June 2023
Development of a Robust Scalable Suspension Platform for AAV Manufacturing up to 2000L
This Briefing from Advanced Therapies
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image

The Cell & Gene Therapy Manufacturing Capacity Map